Wells Fargo’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.28M Buy
311,330
+309,097
+13,842% +$5.6M ﹤0.01% 2279
2025
Q4
$31.7K Buy
2,233
+1,510
+209% +$28.6K ﹤0.01% 5677
2025
Q3
$17.9K Sell
723
-46
-6% -$1.03K ﹤0.01% 5822
2025
Q2
$17.4K Sell
769
-861
-53% -$20.4K ﹤0.01% 5822
2025
Q1
$49.4K Sell
1,630
-484
-23% -$18.4K ﹤0.01% 5401
2024
Q4
$83.8K Sell
2,114
-4,133
-66% -$186K ﹤0.01% 5293
2024
Q3
$396K Sell
6,247
-366
-6% -$26.4K ﹤0.01% 4139
2024
Q2
$447K Sell
6,613
-300
-4% -$20.9K ﹤0.01% 3986
2024
Q1
$548K Buy
6,913
+88
+1% +$7.2K ﹤0.01% 3825
2023
Q4
$531K Buy
6,825
+1,000
+17% +$74K ﹤0.01% 3826
2023
Q3
$410K Sell
5,825
-5,506
-49% -$411K ﹤0.01% 3902
2023
Q2
$902K Sell
11,331
-10,415
-48% -$753K ﹤0.01% 3550
2023
Q1
$1.57M Sell
21,746
-2,832
-12% -$221K ﹤0.01% 3066
2022
Q4
$2.02M Sell
24,578
-774
-3% -$63.8K ﹤0.01% 2776
2022
Q3
$1.98M Buy
25,352
+12,446
+96% +$995K ﹤0.01% 2748
2022
Q2
$873K Sell
12,906
-67,356
-84% -$4.7M ﹤0.01% 3375
2022
Q1
$5.26M Buy
80,262
+6,370
+9% +$370K ﹤0.01% 2416
2021
Q4
$4.49M Buy
73,892
+20,398
+38% +$1.22M ﹤0.01% 2685
2021
Q3
$3.41M Sell
53,494
-8,179
-13% -$516K ﹤0.01% 3203
2021
Q2
$3.87M Buy
61,673
+35,633
+137% +$2.23M ﹤0.01% 3091
2021
Q1
$1.49M Sell
26,040
-28,225
-52% -$1.53M ﹤0.01% 3955
2020
Q4
$2.73M Sell
54,265
-11,453
-17% -$456K ﹤0.01% 3270
2020
Q3
$1.94M Buy
65,718
+18,811
+40% +$546K ﹤0.01% 3339
2020
Q2
$1.18M Buy
46,907
+13,447
+40% +$336K ﹤0.01% 3687
2020
Q1
$614K Sell
33,460
-17,891
-35% -$512K ﹤0.01% 3887
2019
Q4
$1.71M Buy
51,351
+17,271
+51% +$541K ﹤0.01% 3470
2019
Q3
$1.06M Buy
34,080
+700
+2% +$21.3K ﹤0.01% 3791
2019
Q2
$1.17M Sell
33,380
-34,563
-51% -$1.12M ﹤0.01% 3758
2019
Q1
$1.99M Sell
67,943
-2,468
-4% -$69.9K ﹤0.01% 3371
2018
Q4
$1.81M Buy
70,411
+25,558
+57% +$885K ﹤0.01% 3357
2018
Q3
$1.58M Sell
44,853
-4,933
-10% -$197K ﹤0.01% 3591
2018
Q2
$2.04M Buy
49,786
+15,017
+43% +$606K ﹤0.01% 3443
2018
Q1
$1.36M Buy
34,769
+11,951
+52% +$438K ﹤0.01% 3673
2017
Q4
$745K Sell
22,818
-3,043,453
-99% -$105M ﹤0.01% 4114
2017
Q3
$146M Sell
3,066,271
-860,889
-22% -$42M 0.05% 423
2017
Q2
$194M Sell
3,927,160
-1,749,329
-31% -$77.5M 0.06% 318
2017
Q1
$247M Sell
5,676,489
-3,427,912
-38% -$139M 0.08% 252
2016
Q4
$301M Buy
9,104,401
+2,246,619
+33% +$87.2M 0.11% 203
2016
Q3
$340M Buy
6,857,782
+1,581,959
+30% +$82.4M 0.13% 178
2016
Q2
$292M Buy
5,275,823
+118,861
+2% +$6.95M 0.11% 197
2016
Q1
$284M Buy
5,156,962
+827,845
+19% +$47.2M 0.11% 203
2015
Q4
$270M Buy
4,329,117
+1,468,501
+51% +$95.7M 0.11% 218
2015
Q3
$190M Buy
2,860,616
+943,206
+49% +$72.6M 0.08% 283
2015
Q2
$150M Buy
1,917,410
+715,892
+60% +$51.5M 0.06% 370
2015
Q1
$86M Buy
1,201,518
+20,292
+2% +$1.3M 0.03% 546
2014
Q4
$72.3M Sell
1,181,226
-300,714
-20% -$17.5M 0.03% 590
2014
Q3
$71.9M Buy
1,481,940
+81,825
+6% +$4M 0.03% 576
2014
Q2
$63.7M Buy
1,400,115
+90,398
+7% +$3.97M 0.03% 662
2014
Q1
$59.1M Buy
1,309,717
+163,476
+14% +$8.06M 0.03% 676
2013
Q4
$54.3M Buy
1,146,241
+62,484
+6% +$2.72M 0.02% 714
2013
Q3
$42.7M Buy
1,083,757
+163,803
+18% +$6.08M 0.02% 765
2013
Q2
$30.4M Buy
+919,954
New +$29.9M 0.02% 893

Other funds holding ACHC

Wells Fargo's ACHC Position: Q1 2026 in Review

Wells Fargo increased its Acadia Healthcare (ACHC) stake by 13,842% in Q1 2026, buying an estimated $5.6M and bringing the position to 311,330 shares worth $7.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2279.

Wells Fargo first reported a position in ACHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $340M in Q3 2016. 295 funds tracked by Wall St. Rank hold ACHC as of Q1 2026.

  • Wells Fargo held 311,330 shares of Acadia Healthcare worth $7.28M as of Q1 2026.
  • Wells Fargo bought 309,097 Acadia Healthcare shares in Q1 2026, an estimated $5.6M.
  • Acadia Healthcare made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #2279 holding.
  • Wells Fargo first reported a position in Acadia Healthcare in Q2 2013 and has held it in 52 quarters since.
  • Wells Fargo's Acadia Healthcare position peaked at $340M in Q3 2016.
  • 295 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.